Home
Journal Issues
Current Issue
In Press
Archive
Guidelines
About the journal
Author Guidelines
Peer-Review Policy
Open Access and Copyright
Author Agreement Form
Create Account
Login
Please don't use dangerous characters
Title
Abstract
Full Text
Keywords
Author
First Name
Last Name
Search
eISSN
:
2345-2781
Submit Your Paper
Editorial Board
Publisher
Publication Fee
Contact Us
Archive
Indexing Information
Member of
Follower of
2025, Vol 14, No. 4
×
Journal of Renal Injury Prevention
Chief Editor: Azar Baradaran
Original
1. Evaluation of effects of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors on estimated glomerular filtration rate, albuminuria and weight in diabetic kidney disease: A prospective cohort study
Hayder Aledan*
, Sattar Jabar Saadi
, Jawad Rasheed
J Renal Inj Prev
. 2023;12(3): e32062.
doi:
10.34172/jrip.2023.32062
Scopus ID:
85166024243
Article
PDF
XML
Cited By:
0
0
×
Evaluation of effects of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors on estimated glomerular filtration rate, albuminuria and weight in diabetic kidney disease: A prospective cohort study
Mini-Review
2. SGLT2 inhibitors for the treatment of pulmonary hypertension; new trends
Mohammad Memarian
, Rahimeh Eskandarian*
J Renal Inj Prev
. 2025;14(3): e38409.
doi:
10.34172/jrip.2025.38409
Article
PDF
XML
Cited By:
×
SGLT2 inhibitors for the treatment of pulmonary hypertension; new trends
Review
3. Emerging trends in renoprotective agents; a pharmacological perspective for world kidney day 2025
Zahra Bazargani*
J Renal Inj Prev
. 2025;14(2): e38444.
doi:
10.34172/jrip.2025.38444
Article
PDF
XML
Cited By:
×
Emerging trends in renoprotective agents; a pharmacological perspective for world kidney day 2025
